Topic: Medical Drug Therapy
isnare | 2009-12-15 19:38:48
Ovarian cancer represents about 25% of all female genital tract malignancies. However, there are more deaths from ovarian cancer each year in the United States than from endometrial cancer and cervical cancer combined. The lifetime risk of developing spontaneous ovarian cancer is about 1.7%. Epithelial ovarian cancer was expected cause 15,520 deaths in 2008. Mean age at diagnosis ...
AP News | 2009-12-14 17:41:39
<div id="subtitle">FDA says OSI's Tarceva appears effective against lung cancer as chemotherapy follow-up</div><div><p>Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy.</p><p>The Food ...
Reuters US Online Report Health News | 2009-12-14 14:13:32
<div><p>NEW YORK (Reuters Health) - An herb used since ancient times to treat liver ailments may help reduce the liver damage caused by some cancer drugs, a study published Monday suggests.</p><p>In a study of 50 children undergoing chemotherapy for acute lymphoblastic leukemia (ALL), researchers found that an herb ...
Reuters US Online Report Health News | 2009-12-12 01:03:17
<div><p>CHICAGO (Reuters) - U.S. researchers may have found a way to overcome resistance to hormone-blocking breast cancer drugs, extending the life of treatments that keep the disease in check.</p><p>They said the drug Nexavar or sorafenib, made by German drugmaker Bayer and its development partner Onyx Pharmaceuticals, helped ...
